These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32291133)

  • 1. Synthetic approaches towards bedaquiline and its derivatives.
    Calvert MB; Furkert DP; Cooper CB; Brimble MA
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127172. PubMed ID: 32291133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.
    Patel RV; Riyaz SD; Park SW
    Curr Top Med Chem; 2014; 14(16):1866-74. PubMed ID: 25262806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.
    Divita KM; Khatik GL
    Curr Top Med Chem; 2021; 21(18):1623-1643. PubMed ID: 34517802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.
    He C; Preiss L; Wang B; Fu L; Wen H; Zhang X; Cui H; Meier T; Yin D
    ChemMedChem; 2017 Jan; 12(2):106-119. PubMed ID: 27792278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure.
    Wu C; Luo J; Wu M; Meng F; Cai Z; Chen Y; Sun T
    Med Chem; 2020; 16(5):703-714. PubMed ID: 31203803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel triaryldimethylaminobutan-2-ol derivatives against Mycobacterium tuberculosis.
    Liu P; Fan S; Wang B; Cao R; Wang X; Li S; Lu Y; Zhong W
    Bioorg Chem; 2020 Sep; 102():104054. PubMed ID: 32663665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel.
    Sutherland HS; Tong AST; Choi PJ; Blaser A; Conole D; Franzblau SG; Lotlikar MU; Cooper CB; Upton AM; Denny WA; Palmer BD
    Bioorg Med Chem; 2019 Apr; 27(7):1292-1307. PubMed ID: 30803745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents.
    Singh BK; Yadav AK; Kumar B; Gaikwad A; Sinha SK; Chaturvedi V; Tripathi RP
    Carbohydr Res; 2008 May; 343(7):1153-62. PubMed ID: 18346719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors.
    Dhulap A; Banerjee P
    Curr Drug Targets; 2021; 22(11):1207-1221. PubMed ID: 33480344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
    Diacon AH; Pym A; Grobusch MP; de los Rios JM; Gotuzzo E; Vasilyeva I; Leimane V; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; De Paepe E; van Heeswijk RP; Dannemann B;
    N Engl J Med; 2014 Aug; 371(8):723-32. PubMed ID: 25140958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.
    Nguyen TV; Cao TB; Akkerman OW; Tiberi S; Vu DH; Alffenaar JW
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1025-37. PubMed ID: 27322153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline.
    Blaser A; Sutherland HS; Tong AST; Choi PJ; Conole D; Franzblau SG; Cooper CB; Upton AM; Lotlikar M; Denny WA; Palmer BD
    Bioorg Med Chem; 2019 Apr; 27(7):1283-1291. PubMed ID: 30792104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 16. Bedaquiline. More data needed on this dangerous antitubercular drug.
    Prescrire Int; 2014 Oct; 23(153):232-4. PubMed ID: 25964964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily Dosing for Bedaquiline in Patients with Tuberculosis.
    Salinger DH; Nedelman JR; Mendel C; Spigelman M; Hermann DJ
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMC207 becomes bedaquiline, a new anti-TB drug.
    Palomino JC; Martin A
    Future Microbiol; 2013 Sep; 8(9):1071-80. PubMed ID: 24020736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedaquiline for the treatment of pulmonary, multidrug-resistant tuberculosis in adults.
    Gras J
    Drugs Today (Barc); 2013 Jun; 49(6):353-61. PubMed ID: 23807939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues with the use of bedaquiline.
    Kakkar AK; Dahiya N
    Ann Pharmacother; 2014 May; 48(5):666. PubMed ID: 24519480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.